350 related articles for article (PubMed ID: 18178037)
1. [Antibacterial spectrum of an antibiotic and clinical categorization].
Cavallo JD; Mérens A
Pathol Biol (Paris); 2008 Jul; 56(5):300-4. PubMed ID: 18178037
[TBL] [Abstract][Full Text] [Related]
2. Harmonization of antimicrobial susceptibility testing breakpoints in Europe: implications for reporting intermediate susceptibility.
Brown D; Macgowan A
J Antimicrob Chemother; 2010 Feb; 65(2):183-5. PubMed ID: 19996143
[TBL] [Abstract][Full Text] [Related]
3. [Antimicrobial susceptibility testing of bacteria isolated from animals: considerations concerning the predefinition of breakpoints from the clinical pharmacological viewpoint].
Kietzmann M; Böttner A; Hafez HM; Kehrenberg C; Klarmann D; Krabisch P; Kühn T; Luhofer G; Richter A; Schwarz S; Traeder W; Waldmann KH; Wallmann J; Werckenthin C; ;
Berl Munch Tierarztl Wochenschr; 2004; 117(3-4):81-7. PubMed ID: 15046455
[TBL] [Abstract][Full Text] [Related]
4. [Antimicrobial susceptibility testing of bacteria isolated from animals: methods for in-vitro susceptibility testing and their suitability with regard to the generation of the most useful data for therapeutic applications].
Schwarz S; Böttner A; Hafez HM; Kehrenberg C; Kietzmann M; Klarmann D; Klein G; Krabisch P; Kühn T; Luhofer G; Richter A; Traeder W; Waldmann KH; Wallmann J; Werckenthin C
Berl Munch Tierarztl Wochenschr; 2003; 116(9-10):353-61. PubMed ID: 14526464
[TBL] [Abstract][Full Text] [Related]
5. Antimicrobial susceptibility testing in Sweden. II. Species-related zone diameter breakpoints to avoid interpretive errors and guard against unrecognized evolution of resistance.
Ringertz S; Olsson-Liljequist B; Kahlmeter G; Kronvall G
Scand J Infect Dis Suppl; 1997; 105():8-12. PubMed ID: 9435026
[TBL] [Abstract][Full Text] [Related]
6. [Pseudomonas aeruginosa and beta-lactam antibiotics at the time of Europe].
Cavallo JD; Mérens A
Pathol Biol (Paris); 2008; 56(7-8):435-8. PubMed ID: 19019568
[TBL] [Abstract][Full Text] [Related]
7. Breakpoints for intravenously used cephalosporins in Enterobacteriaceae--EUCAST and CLSI breakpoints.
Kahlmeter G
Clin Microbiol Infect; 2008 Jan; 14 Suppl 1():169-74. PubMed ID: 18154542
[TBL] [Abstract][Full Text] [Related]
8. Breakpoints in in-vitro antibiotic sensitivity testing. Report by a working party of the British Society for Antimicrobial Chemotherapy.
J Antimicrob Chemother; 1988 Jun; 21(6):701-10. PubMed ID: 3410798
[No Abstract] [Full Text] [Related]
9. European harmonization of MIC breakpoints for antimicrobial susceptibility testing of bacteria.
Kahlmeter G; Brown DF; Goldstein FW; MacGowan AP; Mouton JW; Osterlund A; Rodloff A; Steinbakk M; Urbaskova P; Vatopoulos A
J Antimicrob Chemother; 2003 Aug; 52(2):145-8. PubMed ID: 12837738
[No Abstract] [Full Text] [Related]
10. [Proposals of the working group "Antibiotic resistance" for the configuration of microtitre plates to be used in routine antimicrobial susceptibility testing of bacterial pathogens from infections of large food-producing animals and mastitis cases].
Luhofer G; Böttner A; Hafez HM; Kaske M; Kehrenberg C; Kietzmann M; Klarmann D; Klein G; Krabisch P; Kühn T; Richter A; Sigge C; Traeder W; Waldmann KH; Wallmann J; Werckenthin C; Schwarz S;
Berl Munch Tierarztl Wochenschr; 2004; 117(7-8):245-51. PubMed ID: 15298050
[TBL] [Abstract][Full Text] [Related]
11. Should we reevaluate antibiotic breakpoints?
Ferraro MJ
Clin Infect Dis; 2001 Sep; 33 Suppl 3():S227-9. PubMed ID: 11524723
[TBL] [Abstract][Full Text] [Related]
12. [First Argentine consensus guidelines for in vitro antimicrobial susceptibility testing of clinically relevant anaerobic bacteria in humans/ Anaerobic Subcommittee of the Asociación Argentina de Microbiología].
Legaria MC; Bianchini HM; Castello L; Carloni G; Di Martino A; Fernández Canigia L; Litterio M; Rollet R; Rossetti A; Predari SC
Rev Argent Microbiol; 2011; 43(1):51-66. PubMed ID: 21491069
[TBL] [Abstract][Full Text] [Related]
13. Antimicrobial susceptibility breakpoints: PK-PD and susceptibility breakpoints.
Ambrose PG
Treat Respir Med; 2005; 4 Suppl 1():5-11. PubMed ID: 15846151
[TBL] [Abstract][Full Text] [Related]
14. Antibiotic sensitivity testing: correlations between in vitro tests in vivo situations.
Devriese LA; Dutta GN
Ann Rech Vet; 1981; 12(1):41-6. PubMed ID: 7044256
[TBL] [Abstract][Full Text] [Related]
15. Resistance testing of meningococci: the recommendations of the European Monitoring Group on Meningococci.
Vázquez JA
FEMS Microbiol Rev; 2007 Jan; 31(1):97-100. PubMed ID: 17147689
[TBL] [Abstract][Full Text] [Related]
16. Harmonisation of resistance monitoring programmes in veterinary medicine: an urgent need in the EU?
Silley P; de Jong A; Simjee S; Thomas V
Int J Antimicrob Agents; 2011 Jun; 37(6):504-12. PubMed ID: 21295449
[TBL] [Abstract][Full Text] [Related]
17. The effect of interlaboratory variability on antimicrobial susceptibility determination.
Annis DH; Craig BA
Diagn Microbiol Infect Dis; 2005 Sep; 53(1):61-4. PubMed ID: 16182077
[TBL] [Abstract][Full Text] [Related]
18. BSAC standardized disc susceptibility testing method (version 10).
Andrews JM; Howe RA;
J Antimicrob Chemother; 2011 Dec; 66(12):2726-57. PubMed ID: 21921076
[TBL] [Abstract][Full Text] [Related]
19. [Broth microdilution test for the standardized determination of minimal inhibitory and minimal bactericidal concentrations of antimicrobial drugs in rapidly growing aerobic bacteria].
Klare I; Witte W
Z Gesamte Hyg; 1988 Feb; 34(2):111-5. PubMed ID: 3369199
[No Abstract] [Full Text] [Related]
20. In vitro testing of antimicrobial agents.
Washington JA
Infect Dis Clin North Am; 1989 Sep; 3(3):375-87. PubMed ID: 2671127
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
